Gleason Group, Inc. Pear Therapeutics, Inc. Call Options Transaction History

Gleason Group, Inc.

  • $546 Million
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding PEAR

# of Institutions
2
Shares Held
23M
Call Options Held
0
Put Options Held
0
View Full List

About Pear Therapeutics, Inc.

PEAR Quotes by TradingView
  • Ticker PEAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 138,768,992
  • Market Cap $1.39M
  • Description
  • Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...
More about PEAR
Track This Portfolio

Track Gleason Group, Inc. Portfolio

Follow Gleason Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gleason Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gleason Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email